Find Unlimited Emails.For Free.
Discover prospects, find their business emails, and build your pipeline with Unifers.
Start for FreeJoshua Kepnes
Director, Commercial Training & Development @Ascendis Pharma
Signup · Get unlimited contacts
WORK HISTORY
Director, Commercial Training & Development @Ascendis Pharma
Princeton, NJ, US
Responsible for creating strategic training plans, designing and delivering commercial training across 3 different rare disease states with 4 different indications (Pediatric and Adult Growth Hormone Deficiency, Hypoparathyroidism and Achondroplasia). Curriculum supports 2 different Sales teams, Field Reimbursement Managers (FRMs), Market Access and Patient Services.• Designed and implemented training plan for launching Yorvipath in a phased approach in Adult Endocrinology• Led development of training curriculum (emodules, trainings and workshops) for Achondroplasia Disease State awareness ahead of PDUFA as well as a new indication for Adult Growth Hormone Deficiency for Skytrofa and launched with the commercial teams• Designed and launched first Patient Access Liaison (PAL) team within patient services across 2 brands• Created and launched organization’s first behavioral competencies for the sales teams• Implemented first field coaching report (FCR) via iCoach to be used by Regional Sales Directors (RSDs)• Designed and launched organization’s first Leadership Development/Regional Trainer Program (SPARK) across 2 sales teams and FRM team aimed at creating strong peer leaders within the field• Partners cross functionally with compliance, legal, medical and regulatory to create trainings via the PRC process• Conducts field rides as needed to gain field intelligence and design real world training for sales teams• Manage 2 Associate Directors in Commercial Training
EDUCATION
Babson College
Bachelor of Science (B.S.), Marketing
SKILLS
ABOUT JOSHUA KEPNES
I began my medical sales career at GSK in 2003 and Forest Pharmaceuticals in 2007 gaining a strong foundation of medical/pharmaceutical sales. In 2011, I transitioned into disposable medical devices where I had success selling in the New England market winning multiple awards for sales achievement. In 2014, was promoted to Regional Manager at Wellspect Healthcare where I successfully led a team of 7 DMs throughout the Northeast US. It was in this role that I recognized that I really enjoyed the training and development aspect of my job and decided to focus on training full time. In 2017, an opportunity at Shire Pharmaceuticals came to me in the training department where my training career began in rare disease. Shire was purchased by Takeda and simultaneously, I was promoted to focus on Field Leadership Development focusing on developing individual contributors as well as leaders. In 2020, I transitioned into Alnylam where I was able to continue my journey in the rare disease space also expanding my training experience to include sales, thought leader liaisons, patient services, IDN, field reimbursement and market access while also continuing to create and facilitate leadership development programs within the organization.Recognitions include: 2023 Jupiter Award based on outstanding achievement in U.S. Commercial TrainingProduced national Rookie Of The Year awards from region in 2014 and 2016Named top DSM within Wellspect HealthCare in the US sales force for 2 years in a row 2012 and 2013Sales award for highest number of prescriptions through direct revenues for 2013Sales award for highest direct revenue in 2013Sales award for highest volume growth through indirect 2013 Specialties: Leadership Development, Sales Training, Rare Disease Training, Sales, Pharmaceutical Sales, Recruiting, Managed Care, Marketing, Market Access, IDN, Analysis, Hospital Sales, Sold within Cardiology, Pulmonary, Internal Medicine, Rheumatology, Pain Management, Endocrinology, Urology, DME, Medical Device, Rare Disease
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.


